four
differ
human
coronavirus
hcov
circul
worldwid
caus
mostli
mild
selflimit
respiratori
tract
infect
outbreak
sever
acut
respiratori
syndrom
sar
epidem
clearli
demonstr
coronavirus
newli
introduc
human
popul
rapidli
becom
pandem
high
rate
associ
case
fatal
septemb
novel
hcov
emerg
middl
east
sever
clinic
present
resembl
sarscov
prototyp
isol
new
viru
term
hcoverasmu
medic
center
hcovemc
may
world
health
organ
adopt
new
name
viru
middl
east
respiratori
syndrom
coronaviru
merscov
describ
complet
clinic
cours
patient
infect
merscov
precautionari
measur
taken
viru
seem
led
secondari
infect
patient
first
treat
local
hospit
qatar
transfer
specialist
lung
centr
essen
germani
previous
healthi
qatari
male
admit
local
hospit
qatar
highgrad
fever
short
breath
tachypnoea
tachycardia
octob
addit
clinic
symptom
includ
cough
malais
pronounc
tired
symptom
suddenli
appear
week
prior
admiss
patient
deni
past
histori
chronic
diseas
howev
report
longterm
smoke
habit
two
three
pack
cigarett
day
past
year
pulmonari
auscult
reveal
diffus
predominantli
rightsid
crackl
find
complet
agreement
chest
radiographi
cxr
find
diffus
bilater
pulmonari
infiltr
pronounc
right
lower
lobe
sever
communityacquir
pneumonia
suspect
treatment
ceftriaxon
oseltamivir
commenc
despit
antibiot
treatment
patient
respiratori
statu
deterior
h
later
requir
intub
mechan
ventil
antibiot
therapi
chang
broadspectrum
antibiot
includ
piperacillintazobactam
azithromycin
cours
oseltamivir
sustain
none
microbiolog
virolog
diagnost
initi
time
yield
clue
pathogen
regardless
remedi
measur
highgrad
fever
persist
patient
condit
fail
improv
follow
day
respiratori
statu
deterior
acut
kidney
injuri
addit
complic
clinic
cours
diagnosi
acut
respiratori
distress
syndrom
ard
unknown
origin
patient
transfer
treatment
essen
germani
octob
day
hospit
admiss
intens
care
unit
icu
patient
haemodynam
stabl
poor
respiratori
condit
present
hypercapnia
respiratori
acidosi
partial
pressur
oxygen
arteri
blood
mmhg
mmhg
requir
high
level
oxygen
suppli
fraction
inspir
oxygen
well
highposit
end
expiratori
pressur
peep
ventil
subsequ
cxr
reveal
progress
deterior
diffus
interstiti
infiltr
comput
tomographi
ct
scan
confirm
patchi
bilater
peripher
lesion
fig
initi
laboratori
test
reveal
leukocytosi
gil
refer
rang
gil
neutrophil
differenti
count
elev
inflammatori
paramet
kidney
function
return
normal
creatinin
level
mgdl
admiss
icu
bronchoalveolar
lavag
bal
perform
subsequ
examin
bal
cultur
reveal
presenc
multidrugresist
pseudomona
aeruginosa
resist
penicillin
cephalosporin
fluoroquinolon
reduc
suscept
carbapenem
staphylococcu
epidermidi
antibiot
treatment
switch
colistin
clarithrimycin
imipenemcilastatin
vancomycin
cytolog
examin
bal
fluid
show
elev
neutrophil
count
presenc
fungal
pathogen
like
aspergillu
fumigatu
antifung
therapi
voriconazol
start
one
week
later
eosinophilia
differenti
count
elev
serum
immunoglobulin
ig
e
level
iuml
refer
rang
iuml
note
rais
suspicion
allerg
bronchopulmonari
aspergillosi
addit
caus
patient
prolong
respiratori
failur
prednisolon
treatment
mgday
commenc
period
week
produc
prompt
improv
patient
symptom
oxygen
suppli
peep
reduc
gradual
base
find
crx
ct
scan
chest
find
oxygen
statu
improv
patient
becam
stabl
ventil
wean
began
novemb
patient
extub
time
right
lung
infiltr
mostli
resolv
fig
result
test
lung
function
within
normal
rang
could
walk
without
breathless
patient
discharg
hospit
novemb
day
hospit
day
patient
discharg
inform
bronchial
specimen
taken
octob
qatar
test
posit
realtim
reversetranscript
rt
pcr
novelhcov
prior
receiv
inform
treat
physician
taken
possibl
merscov
infect
account
test
result
commun
novemb
rtpcr
perform
describ
corman
et
al
store
specimen
origin
initi
bal
upon
admiss
essen
day
hospit
test
posit
merscovrna
target
rtpcr
patient
nasopharyng
aspir
taken
novemb
neg
assay
attempt
isol
viru
sampl
unsuccess
immunofluoresc
assay
perform
describ
corman
et
al
use
detect
antibodi
produc
respons
merscovinfect
serolog
test
confirm
infect
merscov
patient
specif
antimerscovigmtitr
week
ill
igm
titr
week
ill
seroconvers
occur
igm
titr
decreas
igg
titr
case
present
sever
respiratori
distress
syndrom
caus
infect
merscov
complic
secondari
pneumonia
multidrugresist
p
aeruginosa
also
suspicion
concomit
allerg
bronchopulmonari
aspergillosi
abpa
diagnosi
hcov
infect
remain
elus
patient
discharg
patient
present
rapidli
develop
respiratori
failur
lead
sever
ard
surviv
infect
discharg
hospit
without
remain
defici
lung
function
septemb
two
case
respiratori
failur
induc
novel
human
cov
report
end
march
total
laboratoryconfirm
infect
novel
coronaviru
report
includ
lead
death
like
patient
patient
middleag
male
resid
arabian
peninsula
deni
recent
travel
histori
foreign
countri
rememb
contact
anyon
respiratori
symptom
prior
onset
ill
date
littl
known
transmiss
pattern
sever
clinic
impact
novel
human
cov
ex
vivo
merscov
product
replic
human
bronchial
lung
organ
cultur
seem
like
merscov
exhibit
featur
vivo
high
concentr
viru
bronchial
system
infect
patient
might
lead
high
contagi
procedur
gener
aerosol
airway
suction
bronchoscopi
particular
consid
potenti
sourc
viru
transmiss
procedur
perform
daili
patient
wherea
engag
healthcar
worker
wore
normal
surgic
mask
without
person
protect
equip
eg
protect
eyewear
etc
due
lack
inform
patient
infect
merscov
routin
measur
isol
protect
taken
whole
cours
patient
treatment
icu
given
natur
viru
time
icu
healthcar
staff
potenti
high
risk
infect
merscov
togeth
public
health
author
therefor
perform
serolog
test
worker
found
evid
infect
merscov
furthermor
case
patient
symptom
merscovinfect
within
famili
circl
acquaint
fact
limit
number
report
proven
infect
may
indic
low
potenti
viru
transmit
readili
human
absenc
effect
vaccin
specif
antivir
therapeut
merscov
infect
treatment
remain
support
merscov
close
relat
sarscov
treatment
sarscov
inhibitori
effect
seen
oseltamivir
also
use
treatment
patient
possibl
benefici
effect
interferon
ribavirin
corticosteroid
observ
cofactor
develop
lung
damag
patient
sar
infect
immunemedi
process
aris
overexuber
immun
respons
consequ
corticosteroid
one
backbon
immunomodulatori
therapi
treatment
sarscov
infect
use
lead
alleg
earli
improv
term
subsid
fever
resolut
cxr
infiltr
better
oxygen
immunemodul
effect
corticosteroid
may
therefor
also
benefici
patient
present
ard
caus
merscovinfect
recent
shown
interferon
reduc
replic
merscov
human
ex
vivo
lung
cultur
therebi
provid
stronger
effect
immunomodulatori
therapi
merscovinfect
patient
respiratori
condit
improv
significantli
treatment
corticosteroid
commenc
addit
primari
infect
suspect
concomit
abpa
aggrav
caus
patient
prolong
respiratori
failur
addit
antimycot
therapi
extend
treatment
corticosteroid
week
indic
clear
pulmonari
infiltr
patient
abpa
case
patient
corticosteroid
administ
week
howev
determin
whether
corticosteroidinduc
improv
respiratori
statu
achiev
treatment
abpa
merscov
infect
seem
probabl
clinic
cours
patient
prolong
due
sever
lung
injuri
primari
induc
merscovinfect
infect
promot
secondari
pulmonari
infect
merscov
potenti
caus
sever
pneumonia
healthi
human
even
immunocompet
patient
infect
promot
secondari
bacteri
fungal
coinfect
lead
sever
cours
diseas
immunomodul
substanc
corticosteroid
interferon
may
benefici
treatment
virusinduc
ard
although
risk
transmiss
human
seem
low
appropri
infect
control
measur
must
taken
merscovinfect
suspect
regard
sever
symptom
clinician
consid
merscov
differenti
diagnosi
case
patient
sever
ard
unknown
origin
